Okadaic acid induces Akt hyperphosphorylation and an oxidative stress-mediated cell death in serum starved SK-N-SH human neuroblastoma cells that are augmented by rapamycin

Neuroscience Letters

Volumn 531, Issue 2, 2012, Pages 74-79

  Edelstein, Jacob ^a   Rockwell, Patricia ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Okadaic acid; Oxidative stress; PP2A; Rapamycin, Akt, mTOR; VEGFR2

Indexed keywords

OKADAIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME INHIBITORS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NEUROBLASTOMA; OKADAIC ACID; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84870415030     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.10.052     Document Type: Article

References (25)

1. Bove J., Martinez-Vicente M., Vila M. Fighting neurodegeneration with rapamycin: mechanistic insights. Nature Reviews Neuroscience 2011, 12:437-452.
2. Choi K.C., Kim S.H., Ha J.Y., Kim S.T., Son J.H. A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death. Journal of Neurochemistry 2010, 112:366-376.
3. Edelstein J., Hao T., Cao Q., Morales L., Rockwell P. Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cells. Cellular Signalling 2011, 23:239-248.
4. Feldman M.E., Apsel B., Uotila A., Loewith R., Knight Z.A., Ruggero D., Shokat K.M. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biology 2009, 7:e38.
5. Feliers D., Chen X., Akis N., Choudhury G.G., Madaio M., Kasinath B.S. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney International 2005, 68:1648-1659.
6. Harston R.K., McKillop J.C., Moschella P.C., Van Laer A., Quinones L.S., Baicu C.F., Balasubramanian S., Zile M.R., Kuppuswamy D. Rapamycin treatment augments both protein ubiquitination and Akt activation in pressure-overloaded rat myocardium. American Journal of Physiology - Heart and Circulatory Physiology 2011, 300:1696-1706.
7. Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes and Development 2004, 18:1926-1945.
8. Hsu P.P., Kang S.A., Rameseder J., Zhang Y., Ottina K.A., Lim D., Peterson T.R., Choi Y., Gray N.S., Yaffe M.B., Marto J.A., Sabatini D.M. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011, 332:1317-1322.
9. Huang J., Manning B.D. A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochemical Society Transactions 2009, 37:217-222.
10. Janssens V., Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochemical Journal 2001, 353:417-439.
11. Kondo M., Oya-Ito T., Kumagai T., Osawa T., Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. Journal of Biological Chemistry 2001, 276:12076-12083.
12. Kuo Y.C., Huang K.Y., Yang C.H., Yang Y.S., Lee W.Y., Chiang C.W. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. Journal of Biological Chemistry 2008, 283:1882-1892.
13. Lee K.W., Chen W., Junn E., Im J.Y., Grosso H., Sonsalla P.K., Feng X., Ray N., Fernandez J.R., Chao Y., Masliah E., Voronkov M., Braithwaite S.P., Stock J.B., Mouradian M.M. Enhanced phosphatase activity attenuates alpha-Synucleinopathy in a mouse model. Journal of Neuroscience 2011, 31:6963-6971.
14. Liao Y., Hung M.C. Physiological regulation of Akt activity and stability. American Journal of Translational Research 2010, 2:19-42.
15. Nogueira V., Park Y., Chen C.C., Xu P.Z., Chen M.L., Tonic I., Unterman T., Hay N. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008, 14:458-470.
16. Riesterer O., Zingg D., Hummerjohann J., Bodis S., Pruschy M. Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells. Oncogene 2004, 23:4624-4635.
17. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.H., Hsu P.P., Bagley A.F., Markhard A.L., Sabatini D.M. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Molecular Cell 2006, 22:159-168.
18. Suizu F., Hiramuki Y., Okumura F., Matsuda M., Okumura A.J., Hirata N., Narita M., Kohno T., Yokota J., Bohgaki M., Obuse C., Hatakeyama S., Obata T., Noguchi M. The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. Developmental Cell 2009, 17:800-810.
19. Wu Y.T., W.Ouyang A.S., Lazorchak D., Liu H.M., Shen B. Su, mTOR complex 2 targets Akt for proteasomal degradation via phosphorylation at the hydrophobic motif. Journal of Biological Chemistry 2011, 286:14190-14198.
20. Xu Y., Kim S.O., Li Y., Han J. Autophagy contributes to caspase-independent macrophage cell death. Journal of Biological Chemistry 2006, 281:19179-19187.
21. Yang W.L., Zhang X., Lin H.K. Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development. Oncogene 2010, 29:4493-4503.
22. Yi K.D., Covey D.F., Simpkins J.W. Mechanism of okadaic acid-induced neuronal death and the effect of estrogens. Journal of Neurochemistry 2009, 108:732-740.
23. Yoon S.Y., Choi J.E., Kweon H.S., Choe H., Kim S.W., Hwang O., Lee H., Lee J.Y., Kim D.H. Okadaic acid increases autophagosomes in rat neurons: implications for Alzheimer's disease. Journal of Neuroscience Research 2008, 86:3230-3239.
24. Zhang H., Bajraszewski N., Wu E., Wang H., Moseman A.P., Dabora S.L., Griffin J.D., Kwiatkowski D.J. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. Journal of Clinical Investigation 2007, 117:730-738.
25. Zoncu R., A.Efeyan D.M. Sabatini, mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Reviews Molecular Cell Biology 2011, 12:21-35.